The Senate passed House Bill 11-38 after a debate that split lawmakers over an added public-health measure. The underlying bill authorizes trained pharmacists to dispense oral and injectable contraceptives under protocols with the Department of Public Health and the Pharmacy Board, allows an initial three‑month supply and up to 12 months on renewal, and requires insurance coverage for the medications. It requires training and patient materials, and participation by pharmacists is voluntary.
Contested add-on — corn masa fortification: Senators debated a separate section added in committee that would mandate fortification of corn masa flour with folic acid. Proponents described it as a targeted public‑health intervention to reduce neural‑tube defects, especially among populations who consume corn masa (including some Latino and gluten‑free populations): “This is one of the top public‑health triumphs of the twentieth century,” an advocate said, citing reductions in spina bifida after wheat fortification. Opponents noted the provision had not been thoroughly vetted and warned the governor could veto the bill if the unfunded or contentious section remained. Following floor debate, Amendment 1 deleting the corn masa section was adopted (yeas 29, nays 22), and the committee substitute as amended passed (yays 49, nays 1).
Votes and outcome: The bill as amended passed by a wide margin and will be enrolled and forwarded to the governor (final tally on passage 49–1). Supporters called the underlying bill a pragmatic means to expand access to contraception in counties without obstetric or gynecological coverage; opponents had concerns only about the attached food‑fortification mandate that was removed.
Why it matters: The measure expands access points for contraceptives by enabling pharmacists—after training and under a public‑health protocol—to dispense medication that previously required a clinician visit. That change may affect rural and medically underserved counties where OB-GYN access is limited. The corn‑masa debate highlighted how public-health add‑ons can imperil otherwise broadly supported bills when not vetted or funded.